Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “BTC”

126 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 126 results

Testing effectiveness (Phase 2)UnknownNCT01811277
What this trial is testing

SOX Sequential S-1 in Advanced Biliary Tract Carcinoma（BTC）and Pancreatic Cancer

Who this might be right for
Biliary Tract CancerPeriampullary AdenocarcinomaPancreatic Cancer
Peking University 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06502080
What this trial is testing

Consolidative Radiotherapy (CSRT) in Patients With Oligometastatic/Locally Advanced Unresectable Bilary Tract Cancer (BTC)

Who this might be right for
Biliary Tract Cancer
Shanghai Zhongshan Hospital 128
Testing effectiveness (Phase 2)Looking for participantsNCT07111546
What this trial is testing

A Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumours[Substudy 02(BTC&HCC)]

Who this might be right for
Advanced Solid Tumour
Nanjing Leads Biolabs Co.,Ltd 140
Testing effectiveness (Phase 2)WithdrawnNCT05019677
What this trial is testing

GP Chemotherapy in Combination With Tislelizumab and Ociperlimab as First-line Treatment in Advanced BTC

Who this might be right for
Intrahepatic Cholangiocarcinoma
Fudan University
Not applicableNot Yet RecruitingNCT07454486
What this trial is testing

TRACE-BTC. Relation of Biomarkers and Patients Reported Quality of Life to Outcomes in Patients With Biliary Tract Cancer: a Real- World Cohort

Who this might be right for
Biliary Tract Cancer (BTC)Biliary Tract Cancer (CCA)Gall Bladder Cancer+11 more
Aarhus University Hospital 300
Not applicableActive Not RecruitingNCT05036486
What this trial is testing

The Registry of Genetic Alterations of Taiwan Biliary Tract Cancer

Who this might be right for
Biliary Tract Cancer (BTC)
National Health Research Institutes, Taiwan 480
Testing effectiveness (Phase 2)Looking for participantsNCT05785741
What this trial is testing

DB-1310 in Advanced/Metastatic Solid Tumors

Who this might be right for
Advanced Solid Tumor
DualityBio Inc. 1,000
Not applicableActive Not RecruitingNCT06975917
What this trial is testing

Adjuvant Chemotherapy Regimens in Resected Biliary Tract Cancers (TOG/GI-SAFRADJU-2501)

Who this might be right for
Biliary Tract CancerBiliary Tract Cancers (BTC)
Ankara University 600
Testing effectiveness (Phase 2)Study completedNCT03929666
What this trial is testing

A Safety and Efficacy Study of ZW25 (Zanidatamab) Plus Combination Chemotherapy in HER2-expressing Gastrointestinal Cancers, Including Gastroesophageal Adenocarcinoma, Biliary Tract Cancer, and Colorectal Cancer

Who this might be right for
HER2-expressing Gastrointestinal Cancers, Including Gastroesophageal Adenocarcinoma, Biliary Tract Cancer, and Colorectal Cancer
Jazz Pharmaceuticals 74
Not applicableLooking for participantsNCT07609641
What this trial is testing

Surgical Total Clearance Versus Extrahepatic Bile Duct Preservation for Biliary Tract Malignancies: A Single-Center, Randomized, Two-Arm, Prospective Phase II Clinical Trial

Who this might be right for
BTC
Tianjin Medical University Cancer Institute and Hospital 60
Testing effectiveness (Phase 2)WithdrawnNCT03768531
What this trial is testing

Safety and Tolerability Study of Nivolumab and Cabiralizumab for Resectable Biliary Tract Cancer

Who this might be right for
Resectable Biliary Tract Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Testing effectiveness (Phase 2)Study completedNCT02425137
What this trial is testing

S-1 in Combination With Gemcitabine as First-Line Treatment in Patients With Advanced Biliary Tract Cancer

Who this might be right for
Advanced Biliary Tract Cancer(BTC)
TTY Biopharm 51
Testing effectiveness (Phase 2)UnknownNCT01821248
What this trial is testing

A Phase II Trial of Preoperative Chemotherapy for Biliary Tract Cancer (BTC) With Node Metastasis

Who this might be right for
Biliary Tract Cancer
Kansai Hepatobiliary Oncology Group 25
Testing effectiveness (Phase 2)UnknownNCT05327582
What this trial is testing

An Open-label, Phase I/II Study of PLENA Regimen in Patients With Unresectable Pancreatic Cancer or BTC

Who this might be right for
Pancreatic CancerBiliary Tract Cancer
Chinese PLA General Hospital 65
Testing effectiveness (Phase 2)Looking for participantsNCT06975410
What this trial is testing

Clinical Trial of YH32364 in Patients With Locally Advanced or Metastatic EGFR Overexpressing Solid Tumors

Who this might be right for
EGFR OverexpressionLocally Advanced Solid TumorMetastatic Solid Tumor
Yuhan Corporation 80
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07129018
What this trial is testing

Trastuzumab Rezetecan Combined With Pertuzumab and Iparomlimab and Tuvonralimab for Biliary Tract Cancer

Who this might be right for
Biliary Tract Cancer (BTC)First-line Therapy
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 63
Testing effectiveness (Phase 2)Active Not RecruitingNCT06490107
What this trial is testing

Durvalumab Combined With S-1 as Adjuvant Therapy of Resectable BTC

Who this might be right for
Biliary Tract Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 40
Testing effectiveness (Phase 2)Looking for participantsNCT05482893
What this trial is testing

Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or ICI, for the Treatment of Patients With Advanced Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study)

Who this might be right for
Gastric or Gastroesophageal Junction AdenocarcinomaPancreatic Ductal AdenocarcinomaBiliary Tract Cancer (BTC)
Phanes Therapeutics 258
Testing effectiveness (Phase 2)UnknownNCT05350943
What this trial is testing

HAIC Combined With Toripalimab and Donafenib for Advanced BTC

Who this might be right for
Biliary Tract Adenocarcinoma
Lu Wang, MD, PhD 70
Not applicableLooking for participantsNCT06653127
What this trial is testing

Circulating Tumor Mitochondrial DNA (ct-mtDNA) As a Biomarker for Biliary Tract Cancer Recurrence Surveillance

Who this might be right for
Biliary Tract Cancer
Tongji Hospital 50
Load More Results